Senzime Ab Stock Fundamentals
| SEZI Stock | SEK 5.78 0.04 0.70% |
Senzime AB fundamentals help investors to digest information that contributes to Senzime AB's financial success or failures. It also enables traders to predict the movement of Senzime Stock. The fundamental analysis module provides a way to measure Senzime AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Senzime AB stock.
Senzime |
Senzime AB Company Return On Equity Analysis
Senzime AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Senzime AB Return On Equity | -0.64 |
Most of Senzime AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Senzime AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Senzime AB has a Return On Equity of -0.6434. This is 97.32% lower than that of the Health Care Equipment & Supplies sector and 92.63% lower than that of the Health Care industry. The return on equity for all Sweden stocks is 107.55% higher than that of the company.
Senzime AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Senzime AB's current stock value. Our valuation model uses many indicators to compare Senzime AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Senzime AB competition to find correlations between indicators driving Senzime AB's intrinsic value. More Info.Senzime AB is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Senzime AB's earnings, one of the primary drivers of an investment's value.Senzime Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Senzime AB's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Senzime AB could also be used in its relative valuation, which is a method of valuing Senzime AB by comparing valuation metrics of similar companies.Senzime AB is currently under evaluation in return on equity category among its peers.
Senzime Fundamentals
| Return On Equity | -0.64 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (8.35) % | |||
| Current Valuation | 771.13 M | |||
| Shares Outstanding | 69.88 M | |||
| Shares Owned By Insiders | 43.52 % | |||
| Shares Owned By Institutions | 17.18 % | |||
| Price To Earning | (25.28) X | |||
| Price To Book | 2.70 X | |||
| Price To Sales | 60.95 X | |||
| Revenue | 10.98 M | |||
| Gross Profit | (4.39 M) | |||
| EBITDA | (73.22 M) | |||
| Net Income | (82.14 M) | |||
| Cash And Equivalents | 74.87 M | |||
| Cash Per Share | 0.42 X | |||
| Total Debt | 617 K | |||
| Current Ratio | 3.78 X | |||
| Book Value Per Share | 3.75 X | |||
| Cash Flow From Operations | (81.33 M) | |||
| Earnings Per Share | (1.37) X | |||
| Target Price | 11.0 | |||
| Number Of Employees | 18 | |||
| Beta | 0.61 | |||
| Market Capitalization | 531.12 M | |||
| Total Asset | 174.62 M | |||
| Working Capital | 16 M | |||
| Current Asset | 18 M | |||
| Current Liabilities | 2 M | |||
| Net Asset | 174.62 M |
About Senzime AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Senzime AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senzime AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senzime AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Senzime AB develops patient-oriented monitoring systems that assess patients biochemical and physiological processes before, during and after surgery in Sweden. Senzime AB was founded in 1997 and is based in Uppsala, Sweden. Senzime AB is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.